Supplement: CRISPR Enters the Clinic
Using CRISPR-Altered Cells to Fight Disease
The Top 10 Highest-Paid Women Executives in Biopharma
Compensation Has Climbed since 2014, yet Gap with Male Counterparts Remains
Growing Antibody Industry in China Sees Major Opportunities
Yet, Challenges Remain as Companies Need More Talent and Resources to Market Globally
Kinetic Imaging: Using Zebrafish to Study Toxicology
Combining the convenience and throughput of multiwell assays with the benefits of a fully functioning organism
For full access to this article login to GEN Select now.
Novel ADMET Technologies Gain Traction
- Too many new drug compounds fail in late-stage clinical trials due to inefficacy and safety concerns. With often-cited costs of $800 million to bring a new drug to market, a compelling need exists for improved early-stage screening. Insufficient knowledge of potential human toxicity can turn a promising lead candidate ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.